Retatrutide a triple agonist (activating GLP-1, GIP, and glucagon receptors) currently in clinical trials for obesity (not yet FDA-approved)
Additionally, exploring catalase as a diagnostic or prognostic biomarker and its neuroprotective attributes in neurodegenerative diseases presents exciting research opportunities
Stay hydrated with water and electrolyte solutions
Speak With a Member of Our New Patient Concierge Team we can answer your questions, help you compare your options, and schedule your first visit
What Is MEDVi and How Is the Platform Structured MEDVi is a telehealth platform that facilitates access to GLP-1 weight loss medications through an online evaluation, clinician assessment, and direct-to-door medication delivery model
Fecal microbiota transplantation ameliorates bone loss in mice with ovariectomy-induced osteoporosis via modulating gut microbiota and metabolic function